Active Surveillance for Prostate Cancer: Evidence-Based Natural and Integrative Therapies. Can diet, exercise, supplements, and lifestyle changes help men with low-risk prostate cancer avoid unnecessary treatment?
A diagnosis of prostate cancer does not always mean that you need immediate surgery, radiation, or hormone therapy. For many men diagnosed with low-risk, localized prostate cancer, active surveillance offers an opportunity to monitor their cancer while avoiding or delaying the possible side effects of conventional treatment.
But active surveillance raises an important question:
While your doctors monitor your prostate cancer, what can you do to improve your health and potentially reduce your risk of progression?
Research has explored nutrition, exercise, weight management, vitamin D, curcumin, green tea, omega-3 fatty acids, and other complementary therapies.
Some of these approaches offer meaningful health benefits. Others have shown encouraging laboratory or preliminary clinical results. However, none has been conclusively demonstrated to prevent low-risk prostate cancer from progressing.
The goal of integrative active surveillance is to combine appropriate medical monitoring with evidence-based lifestyle changes—not to replace monitoring with supplements.
If you are a newly diagnosed Prostate Cancer Patient: Prostate Cancer: Need to Know
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about prostate cancer.
Good luck,
David Emerson
Concepts Central to Managing Your Cancer-
Possible Conventional Therapies
What Patients Need to Know
- Active surveillance is an established management strategy for many men with low-risk prostate cancer.
- Exercise has some of the strongest clinical evidence for improving fitness and quality of life during surveillance.
- A Mediterranean-style dietary pattern supports cardiovascular and metabolic health, although its effect on prostate cancer progression remains uncertain.
- Weight management may improve insulin resistance and other metabolic risk factors.
- Vitamin D supplementation can correct deficiency, but clinical trials have not established it as a treatment for prostate cancer.
- Curcumin, green tea, lycopene, and omega-3 supplements have insufficient evidence to establish that they prevent prostate cancer progression.
- PSA testing, prostate MRI, and repeat biopsy remain essential components of active surveillance.
1. What Is Active Surveillance for Prostate Cancer?
Active surveillance means monitoring a diagnosed prostate cancer rather than immediately treating it with surgery or radiation. It is generally most appropriate for men with localized, low-risk disease, frequently characterized by:
- Gleason score 3+3=6 (Grade Group 1)
- PSA below 10 ng/mL
- Cancer confined to the prostate
- Favorable biopsy findings and limited cancer volume
Selected men with favorable intermediate-risk disease may also be candidates after individualized evaluation.
Active surveillance differs from watchful waiting. Active surveillance is intended to preserve the opportunity for curative treatment if the cancer becomes more aggressive. Watchful waiting generally emphasizes symptom management rather than routine testing intended to detect progression early.
The 2026 NCCN and AUA guidance continues to recognize active surveillance as an important management strategy for appropriately selected patients.
Research: NCCN Prostate Cancer Guidelines, Version 5.2026 and AUA/ASTRO Guideline Amendment, 2026.
2. Exercise During Active Surveillance
Exercise is one of the most promising supportive therapies for men undergoing active surveillance.
Regular physical activity can improve cardiovascular fitness, metabolic health, muscle strength, fatigue, and emotional well-being.
The ERASE randomized clinical trial evaluated 52 men undergoing active surveillance. Participants assigned to 12 weeks of supervised high-intensity interval training experienced improvements in cardiorespiratory fitness.
Researchers also observed favorable changes in PSA-related measurements. However, these were exploratory findings from a small, short-duration study, not proof that exercise prevents prostate cancer progression.
A separate randomized study of a home-based walking program found improvements in aerobic fitness and selected quality-of-life measures.
Practical exercise recommendations
Consider building a program around:
- Walking or other aerobic exercise most days
- Resistance training two or more days per week
- Balance and flexibility exercises
- Gradually increasing physical activity according to ability
A reasonable long-term target for many adults is 150 minutes of moderate aerobic activity weekly, adjusted for age, fitness, and medical limitations.
What the evidence shows: Exercise improves physical fitness and may reduce anxiety during active surveillance. Whether it reduces prostate cancer progression remains uncertain.
Research:
3. Nutrition: Can Diet Influence Prostate Cancer Progression?
Diet is an important part of overall health during active surveillance. A Mediterranean-style eating pattern emphasizes:
- Vegetables and fruits
- Beans and legumes
- Whole grains
- Nuts and seeds
- Olive oil
- Fish and other sources of unsaturated fats
- Limited processed meats and highly processed foods
This pattern can support cardiovascular and metabolic health. But can eating more vegetables slow prostate cancer? The large MEAL randomized clinical trial studied 478 men with early-stage prostate cancer. Researchers evaluated whether intensive counseling to increase vegetable consumption would reduce disease progression.
After two years, the intervention did not significantly reduce prostate cancer progression compared with the control group. This finding does not mean vegetables are unimportant. It means that increasing vegetable consumption alone has not been proven to prevent progression during active surveillance.
Foods worth including
- Tomatoes and lycopene: Tomatoes provide lycopene, a carotenoid studied for possible prostate-related benefits. Clinical evidence is insufficient to recommend lycopene supplements as prostate cancer treatment.
- Cruciferous vegetables: Broccoli, cauliflower, cabbage, and Brussels sprouts contain biologically active compounds that have attracted cancer research interest. Human evidence for preventing progression remains inconclusive.
- Soy foods: Tofu, edamame, and other whole soy foods can provide plant protein. Laboratory and observational findings are interesting, but they do not establish soy supplements as prostate cancer therapy.
Research: The MEAL randomized clinical trial.
Nutrition: Anti-Inflammatory Diet for Prostate Cancer
4. Weight Management and Metabolic Health
Obesity, insulin resistance, and metabolic dysfunction have been investigated as possible influences on prostate cancer outcomes. The Prostate Cancer Active Lifestyle Study (PALS) evaluated a structured diet and exercise intervention among overweight and obese men undergoing active surveillance.
The intervention group achieved approximately 7.1% weight loss compared with 1.8% in the control group. Researchers also documented improvements in insulin-related biomarkers. These results suggest that structured lifestyle interventions can improve metabolic health during surveillance.
However, the study did not establish that weight loss prevents prostate cancer progression. For men who are overweight, improving metabolic health may be a worthwhile goal independent of any direct effect on the tumor.
Research: PALS randomized clinical trial.
5. Vitamin D and Prostate Cancer Active Surveillance
Vitamin D has attracted considerable interest because of its roles in bone health, immune regulation, and cellular processes. An early clinical study evaluated 4,000 IU of vitamin D3 daily in men with low-risk prostate cancer undergoing active surveillance. Among 44 evaluable participants, 55% demonstrated a reduction in positive biopsy cores or Gleason score after one year.
These findings were encouraging, but the study was small and lacked a placebo control group. A more recent randomized trial, ProsD, evaluated vitamin D supplementation in men with low- to intermediate-risk localized prostate cancer undergoing active surveillance. The investigators did not find a significant improvement in progression-free survival or freedom from active treatment.
Should patients take vitamin D?
Men with vitamin D deficiency may benefit from correcting that deficiency for established health reasons, particularly bone health. However, vitamin D should not be presented as a proven prostate cancer treatment.
High-dose supplementation also carries risks, including hypercalcemia and kidney complications. The 4,000 IU dose used in the earlier study should not be interpreted as a recommended cancer-treatment dose.
Research:
6. Curcumin, Green Tea, Omega-3s, and Other Supplements
Many natural compounds have demonstrated biological activity in laboratory studies. But a substance that affects prostate cancer cells in a laboratory does not necessarily improve clinical outcomes in patients.
Curcumin
Curcumin, a compound found in turmeric, has demonstrated anti-inflammatory and anticancer mechanisms in preclinical research. These findings justify further investigation, but there is insufficient high-quality clinical evidence that curcumin prevents progression during active surveillance. Concentrated curcumin products may interact with medications, and some formulations have been associated with liver injury.
Green tea
Green tea contains catechins, including epigallocatechin gallate (EGCG). Preclinical studies suggest possible effects on pathways involved in prostate cancer biology. However, clinical evidence has not established green tea extracts as an effective treatment during active surveillance. Drinking green tea as a beverage is different from taking concentrated extracts, which can cause liver toxicity.
Omega-3 fatty acids
Omega-3 fatty acids, particularly EPA and DHA, have been studied for their anti-inflammatory and metabolic effects. Eating fish as part of a balanced diet may offer cardiovascular benefits. However, omega-3 supplements have not been proven to slow prostate cancer progression during active surveillance. Higher-dose products can also have adverse effects and require medication review.
Lycopene and other antioxidant supplements
Lycopene-rich foods can be included in a healthy dietary pattern, but clinical evidence does not justify treating lycopene capsules or antioxidant combinations as proven anticancer therapies.
Important: Do not combine multiple high-dose supplements without reviewing the complete regimen with your healthcare team.
To Learn More: Prostate Cancer and Nutritional Supplements
7. Stress Reduction, Sleep, and Quality of Life
Living with untreated but monitored cancer can create anxiety. Some patients worry that they are doing nothing while cancer remains in their bodies. This is one reason integrative care can be valuable. Mindfulness, counseling, relaxation techniques, support groups, regular physical activity, and healthy sleep habits may improve emotional well-being.
These strategies should be viewed as supportive care rather than proven methods for controlling prostate cancer. For many patients, preserving quality of life is a central reason for choosing active surveillance in the first place.
8. PeopleBeatingCancer Evidence Rating System
The following ratings distinguish established supportive benefits from evidence that a therapy actually slows prostate cancer.
| Therapy |
Evidence for supportive health benefits |
Evidence for preventing prostate cancer progression |
| Regular exercise |
Strong |
Preliminary/inconclusive |
| Mediterranean-style diet |
Strong for general health |
Inconclusive |
| Weight management when overweight |
Moderate to strong |
Inconclusive |
| Vitamin D when deficient |
Strong for correcting deficiency |
Randomized evidence does not show benefit |
| Curcumin supplements |
Limited clinical evidence |
Insufficient |
| Green tea beverage |
Possible general health benefits |
Insufficient |
| Omega-3-rich foods |
Established nutritional role |
Insufficient |
| Lycopene-rich foods |
Part of a healthy dietary pattern |
Insufficient |
| Mindfulness and stress management |
Moderate for psychological support |
No established benefit |
How to interpret these ratings: A therapy may be beneficial for cardiovascular health, fitness, or emotional well-being without being a proven prostate cancer treatment. Laboratory findings, biomarker changes, and small uncontrolled trials receive less weight than randomized trials with meaningful clinical outcomes.
9. What Does an Integrative Active Surveillance Plan Look Like?
A practical plan combines conventional monitoring with supportive lifestyle changes.
| Area |
Suggested approach |
| Medical surveillance |
Follow the urologist’s individualized PSA, MRI, and biopsy schedule |
| Nutrition |
Emphasize Mediterranean-style whole foods |
| Physical activity |
Combine aerobic activity and resistance exercise |
| Metabolic health |
Address excess weight, diabetes, blood pressure, and cholesterol |
| Supplements |
Correct documented deficiencies; review potential risks and interactions |
| Emotional health |
Use counseling, mindfulness, exercise, or peer support when helpful |
| Sleep |
Maintain a consistent sleep schedule and address sleep disorders |
The goal is not to assemble the largest possible supplement regimen. The goal is to improve overall health while leaving room for curative treatment if the cancer progresses.
10. When Is Active Surveillance No Longer Appropriate?
Lifestyle therapies must never become a reason to ignore evidence of disease progression. Changes that may require further evaluation include:
- Biopsy upgrading to a more aggressive Grade Group
- Increasing cancer volume on biopsy
- Concerning changes on prostate MRI
- Persistent PSA changes that warrant reassessment
- Other evidence that the cancer no longer meets appropriate surveillance criteria
A PSA increase alone does not necessarily mean that immediate treatment is required. It may instead prompt repeat testing, MRI, or biopsy. The decision to move from surveillance to treatment should be based on the overall clinical picture and patient preferences.
Considering conventional treatment?: Prostate Cancer: Balancing Conventional and Non-Conventional Therapies
11. Questions to Ask Your Urologist
- Does my cancer still meet the criteria for active surveillance?
- What findings would make you recommend surgery or radiation?
- What exercise program is appropriate for my health?
- Should I be evaluated for vitamin D deficiency?
- Could any of my supplements interfere with medications or future treatment?
- How can I improve cardiovascular and metabolic health during surveillance?
- How should we balance my risk of progression against my quality of life?
Conclusion: Active Surveillance Does Not Mean Doing Nothing
Men with low-risk prostate cancer may be able to avoid or delay surgery, radiation, and their potential side effects through appropriate active surveillance. During that time, patients can take meaningful steps to improve physical fitness, nutrition, metabolic health, sleep, and emotional well-being.
Exercise and healthy lifestyle changes have real benefits, even when their effects on prostate cancer progression remain uncertain. Supplements such as vitamin D, curcumin, green tea extract, and omega-3s should be evaluated individually rather than assumed to be effective anticancer treatments.
The most defensible integrative approach is to maintain evidence-based medical surveillance while using complementary therapies to improve overall health and quality of life.
PeopleBeatingCancer supports informed decision-making that considers both the potential benefits of treatment and the long-term consequences of overtreatment.
Medical disclaimer: This article is educational and is not a substitute for individualized advice from a urologist or oncology team. Active surveillance requires ongoing medical monitoring.
Vitamin D and PCa: Higher intake improves active surveillance outcomes
“PCa will affect 1 in 6 men. However, the disease will be fatal in only 1 in 36, due to its potential for slow growth.1Urologists often monitor the slower, low-risk cases to determine which will evolve into more significant and aggressive disease…
The cure—meaning surgery or radiation—is probably worse than the disease, so they wait a year and then do another biopsy to see where the patient stands.…”
After 1 year, more than half of the participants in the active surveillance group demonstrated improvement on the vitamin D regimen, as shown by a decreased number of positive cores at repeat biopsy. The group concluded that men with low-risk PCa who are undergoing active surveillance might derive benefit from taking 4,000 IU of vitamin D3 per day, without experiencing side effects from the treatment…”
APPIP ERROR: amazonproducts[
AccessDeniedAwsUsers|The Access Key Id AKIAJAJ37JVNL7OUU4CA is not enabled for accessing this version of Product Advertising API. Please migrate your credentials as referred here https://webservices.amazon.com/paapi5/documentation/migrating-your-product-advertising-api-account-from-your-aws-account.html.
]